1
|
Simmonds WM, Awuku Y, Barrett C, Brand M, Davidson K, Epstein D, Fredericks E, Gabriel S, Grobler S, Gounden C, Katsidzira L, Louw VJ, Naidoo V, Noel C, Ogutu E, Ramonate N, Seabi N, Setshedi M, Van Zyl J, Watermeyer G, Kassianides C. Guidance for the gastrointestinal evaluation and management of iron deficiency in Sub-Saharan Africa. S Afr Med J 2024; 114:e711. [PMID: 38525666 DOI: 10.7196/samj.2024.v114i1b.711] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2023] [Indexed: 03/26/2024] Open
Abstract
BACKGROUND Over 30% of the world's population is anaemic, with a significant proportion of these being iron deficient. As iron deficiency (ID) anaemia in men and post-menopausal women is mostly caused by gastrointestinal blood loss or malabsorption, the initial evaluation of a patient with ID anaemia involves referral to a gastroenterologist. The current drive towards patient blood management in sub-Saharan Africa (SSA)prescribes that we regulate not only the use of blood transfusion but also the management of patients in whom the cause of iron loss or inadequate iron absorption is sought. Recommendations have been developed to: (i) aid clinicians in the evaluation of suspected gastrointestinal iron loss and iron malabsorption, and often a combination of these; (ii) improve clinical outcomes for patients with gastrointestinal causes of ID; (iii) provide current, evidence-based, context-specific recommendations for use in the management of ID; and (iv) conserve resources by ensuring rational utilisation of blood and blood products. METHOD Development of the guidance document was facilitated by the Gastroenterology Foundation of Sub-Saharan Africa and the South African Gastroenterology Society. The consensus recommendations are based on a rigorous process involving 21 experts in gastroenterology and haematology in SSA. Following discussion of the scope and purpose of the guidance document among the experts, an initial review of the literature and existing guidelines was undertaken. Thereafter, draft recommendation statements were produced to fulfil the outlined purpose of the guidance document. These were reviewed in a round-table discussion and were subjected to two rounds of anonymised consensus voting by the full committee in an electronic Delphi exercise during 2022 using the online platform, Research Electronic Data Capture. Recommendations were modified by considering feedback from the previous round, and those reaching a consensus of over 80% were incorporated into the final document. Finally, 44 statements in the document were read and approved by all members of the working group. CONCLUSION The recommendations incorporate six areas, namely: general recommendations and practice, Helicobacter pylori, coeliac disease, suspected small bowel bleeding, inflammatory bowel disease, and preoperative care. Implementation of the recommendations is aimed at various levels from individual practitioners to healthcare institutions, departments and regional, district, provincial and national platforms. It is intended that the recommendations spur the development of centre-specific guidelines and that they are integrated with the relevant patient blood management protocols. Integration of the recommendations is intended to promote optimal evaluation and management of patients with ID, regardless of the presence of anaemia.
Collapse
Affiliation(s)
- W M Simmonds
- Gastroenterology Division, Department of Internal Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
| | - Y Awuku
- Department of Medicine, University of Health and Allied Sciences, Ho, Ghana.
| | - C Barrett
- School of Clinical Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
| | - M Brand
- Department of General Surgery, School of Medicine, University of Pretoria, South Africa.
| | - K Davidson
- Private practice, IBD nurse specialist, Cape Town, South Africa.
| | - D Epstein
- Division of Gastroenterology, Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.
| | - E Fredericks
- Department of Medicine, Stellenbosch University, South Africa.
| | - S Gabriel
- Gastroenterology Unit, Tygerberg Hospital and Stellenbosch University, South Africa.
| | - S Grobler
- niversitas Netcare Private Hospital, Bloemfontein, South Africa.
| | - C Gounden
- Department of Gastroenterology, School of Clinical Medicine, University of KwaZulu-Natal and Inkosi Albert Luthuli Central Hospital, Durban, South Africa.
| | - L Katsidzira
- Internal Medicine Unit, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
| | - V J Louw
- Division of Clinical Haematology, Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.
| | - V Naidoo
- Department of Gastroenterology, School of Clinical Medicine, University of KwaZulu-Natal and Inkosi Albert Luthuli Central Hospital, Durban, South Africa.
| | - C Noel
- Division of Gastrointestinal Surgery, Department of Surgery, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
| | - E Ogutu
- Department of Internal Medicine, University of Nairobi and Kenyatta National Hospital, Kenya.
| | - N Ramonate
- Gastroenterology Division, Department of Internal Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
| | - N Seabi
- Gastroenterology Division, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa.
| | - M Setshedi
- Division of Gastroenterology, Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.
| | - J Van Zyl
- Department of Internal Medicine, Faculty of Health Sciences, University of the Free State and Netcare Universitas Private Hospital, Bloemfontein, South Africa.
| | - G Watermeyer
- Division of Gastroenterology, Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.
| | - C Kassianides
- Department of Medicine, Faculty of Health Sciences, University of Cape Town and Morningside Mediclinic, Johannesburg, South Africa.
| |
Collapse
|
2
|
Balakrishnan A, Jah A, Lesurtel M, Andersson B, Gibbs P, Harper SJF, Huguet EL, Kosmoliaptsis V, Liau SS, Praseedom RK, Ramia JM, Branes A, Lendoire J, Maithel S, Serrablo A, Achalandabaso M, Adham M, Ahmet A, Al-Sarireh B, Albiol Quer M, Alconchel F, Alejandro R, Alsammani M, Alseidi A, Anand A, Anselmo A, Antonakis P, Arabadzhieva E, de Aretxabala X, Aroori S, Ashley S, Ausania F, Banerjee A, Barabino M, Bartlett A, Bartsch F, Belli A, Beristain-Hernandez J, Berrevoet F, Bhatti A, Bhojwani R, Bjornsson B, Blaz T, Byrne M, Calvo M, Castellanos J, Castro M, Cavallucci D, Chang D, Christodoulis G, Ciacio O, Clavien P, Coker A, Conde-Rodriguez M, D'Amico F, D'Hondt M, Daams F, Dasari B, De Beillis M, de Meijer V, Dede K, Deiro G, Delgado F, Desai G, Di Gioia A, Di Martino M, Dixon M, Dorovinis P, Dumitrascu T, Ebata T, Eilard M, Erdmann J, Erkan M, Famularo S, Felli E, Fergadi M, Fernandez G, Fox A, Galodha S, Galun D, Ganandha S, Garcia R, Gemenetzis G, Giannone F, Gil L, Giorgakis E, Giovinazzo F, Giuffrida M, Giuliani T, Giuliante F, Gkekas I, Goel M, Goh B, Gomes A, Gruenberger T, Guevara O, Gulla A, Gupta A, Gupta R, Hakeem A, Hamid H, Heinrich S, Helton S, Heumann A, Higuchi R, Hughes D, Inarejos B, Ivanecz A, Iwao Y, Iype S, Jaen I, Jie M, Jones R, Kacirek K, Kalayarasan R, Kaldarov A, Kaman L, Kanhere H, Kapoor V, Karanicolas P, Karayiannakis A, Kausar A, Khan Z, Kim DS, Klose J, Knowles B, Koh P, Kolodziejczyk P, Komorowski A, Koong J, Kozyrin I, Krishna A, Kron P, Kumar N, van Laarhoven S, Lakhey P, Lanari J, Laurenzi A, Leow V, Limbu Y, Liu YB, Lob S, Lolis E, Lopez-Lopez V, Lozano R, Lundgren L, Machairas M, Magouliotis D, Mahamid A, Malde D, Malek A, Malik H, Malleo G, Marino M, Mayo S, Mazzola M, Memeo R, Menon K, Menzulin R, Mohan R, Morgul H, Moris D, Mulita F, Muttillo E, Nahm C, Nandasena M, Nashidengo P, Nickkholgh A, Nikov A, Noel C, O'Reilly D, O'Rourke T, Ohtsuka M, Omoshoro-Jones J, Pandanaboyana S, Pararas N, Patel R, Patkar S, Peng J, Perfecto A, Perinel J, Perivoliotis K, Perra T, Phan M, Piccolo G, Porcu A, Primavesi F, Primrose J, Pueyo-Periz E, Radenkovic D, Rammohan A, Rowcroft A, Sakata J, Saladino E, Schena C, Scholer A, Schwarz C, Serrano P, Silva M, Soreide K, Sparrelid E, Stattner S, Sturesson C, Sugiura T, Sumo M, Sutcliffe R, Teh C, Teo J, Tepetes K, Thapa P, Thepbunchonchai A, Torres J, Torres O, Torzili G, Tovikkai C, Troncoso A, Tsoulfas G, Tuzuher A, Tzimas G, Umar G, Urbani L, Vanagas T, Varga, Velayutham V, Vigano L, Wakai T, Yang Z, Yip V, Zacharoulis D, Zakharov E, Zimmitti G. Heterogeneity of management practices surrounding operable gallbladder cancer - results of the OMEGA-S international HPB surgical survey. HPB (Oxford) 2022; 24:2006-2012. [PMID: 35922277 DOI: 10.1016/j.hpb.2022.06.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/12/2022] [Revised: 06/22/2022] [Accepted: 06/28/2022] [Indexed: 12/12/2022]
Abstract
BACKGROUND Gallbladder cancer (GBC) is an aggressive, uncommon malignancy, with variation in operative approaches adopted across centres and few large-scale studies to guide practice. We aimed to identify the extent of heterogeneity in GBC internationally to better inform the need for future multicentre studies. METHODS A 34-question online survey was disseminated to members of the European-African Hepatopancreatobiliary Association (EAHPBA), American Hepatopancreatobiliary Association (AHPBA) and Asia-Pacific Hepatopancreatobiliary Association (A-PHPBA) regarding practices around diagnostic workup, operative approach, utilization of neoadjuvant and adjuvant therapies and surveillance strategies. RESULTS Two hundred and three surgeons responded from 51 countries. High liver resection volume units (>50 resections/year) organised HPB multidisciplinary team discussion of GBCs more commonly than those with low volumes (p < 0.0001). Management practices exhibited areas of heterogeneity, particularly around operative extent. Contrary to consensus guidelines, anatomical liver resections were favoured over non-anatomical resections for T3 tumours and above, lymphadenectomy extent was lower than recommended, and a minority of respondents still routinely excised the common bile duct or port sites. CONCLUSION Our findings suggest some similarities in the management of GBC internationally, but also specific areas of practice which differed from published guidelines. Transcontinental collaborative studies on GBC are necessary to establish evidence-based practice to minimise variation and optimise outcomes.
Collapse
Affiliation(s)
- Anita Balakrishnan
- Department of HPB Surgery, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, United Kingdom.
| | - Asif Jah
- Department of HPB Surgery, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, United Kingdom
| | - Mickael Lesurtel
- Department of HPB Surgery and Liver Transplantation, Beaujon Hospital, University of Paris Cité, 100 Bd du Général Leclerc, 92110, Clichy, France
| | - Bodil Andersson
- Department of Surgery, Lund University, Skane University Hospital, Lund, Sweden
| | - Paul Gibbs
- Department of HPB Surgery, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, United Kingdom
| | - Simon J F Harper
- Department of HPB Surgery, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, United Kingdom
| | - Emmanuel L Huguet
- Department of HPB Surgery, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, United Kingdom
| | - Vasilis Kosmoliaptsis
- Department of HPB Surgery, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, United Kingdom
| | - Siong S Liau
- Department of HPB Surgery, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, United Kingdom
| | - Raaj K Praseedom
- Department of HPB Surgery, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, United Kingdom
| | - Jose M Ramia
- Department of Surgery, Hospital General Universitario de Alicante, Avenida Pintor Baeza, 12 03010 Alicante, Spain
| | - Alejandro Branes
- Department of HPB Surgery, Hospital Sotero del Rio, Av. Concha y Toro 3459, Puente Alto, Región Metropolitana, Chile
| | - Javier Lendoire
- Department of Surgery, University of Buenos Aires, Hospital Dr Cosme Argerich, Buenos Aires, Argentina
| | - Shishir Maithel
- Department of Surgery, Emory University School of Medicine, Atlanta, GA, 30322 USA
| | - Alejandro Serrablo
- Department of HPB Surgery, Miguel Servet University Hospital, Zaragoza, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Lee D, Sykes J, Griffin K, Noel C, Hyung B, Yao C, Tullis E, Lee J. 37: The impact of chronic rhinosinusitis on the health-related quality of life among adult patients with cystic fibrosis. J Cyst Fibros 2021. [DOI: 10.1016/s1569-1993(21)01462-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
4
|
Noel C, de Pontfarcy A, Mathiaud C, Dalix A, Jolly Sanchez L, Pitsch A, Diamantis S. Listériose chez un nouveau-né par transmission croisée dans un service de néonatalogie. Infect Dis Now 2021. [DOI: 10.1016/j.idnow.2021.06.183] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
5
|
Reda M, Noel C, Settembre N, Chambert J, Lejeune A, Jacquet E. Agent-based modelling of the smooth muscle cells migration induced by mechanical vibration: a preliminary study. Comput Methods Biomech Biomed Engin 2020. [DOI: 10.1080/10255842.2020.1815326] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- M. Reda
- Institut national de recherche et de sécurité (INRS), Vandoeuvre-Lès-Nancy, France
- Department of Applied Mechanics, Univ. Bourgogne Franche-Comté, FEMTO-ST Institute UFC/CNRS/ENSMM/UTBM, Besançon, France
| | - C. Noel
- Institut national de recherche et de sécurité (INRS), Vandoeuvre-Lès-Nancy, France
| | - N. Settembre
- Department of Vascular Surgery, Nancy University Hospital, Nancy, France
| | - J. Chambert
- Department of Applied Mechanics, Univ. Bourgogne Franche-Comté, FEMTO-ST Institute UFC/CNRS/ENSMM/UTBM, Besançon, France
| | - A. Lejeune
- Department of Applied Mechanics, Univ. Bourgogne Franche-Comté, FEMTO-ST Institute UFC/CNRS/ENSMM/UTBM, Besançon, France
| | - E. Jacquet
- Department of Applied Mechanics, Univ. Bourgogne Franche-Comté, FEMTO-ST Institute UFC/CNRS/ENSMM/UTBM, Besançon, France
| |
Collapse
|
6
|
Vantyghem MC, Chetboun M, Gmyr V, Jannin A, Espiard S, Le Mapihan K, Raverdy V, Delalleau N, Machuron F, Hubert T, Frimat M, Van Belle E, Hazzan M, Pigny P, Noel C, Caiazzo R, Kerr-Conte J, Pattou F. Erratum. Ten-Year Outcome of Islet Alone or Islet After Kidney Transplantation in Type 1 Diabetes: A Prospective Parallel-Arm Cohort Study. Diabetes Care 2019;42:2042-2049. Diabetes Care 2020; 43:1164. [PMID: 32152135 PMCID: PMC7171950 DOI: 10.2337/dc20-er05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
|
7
|
Vasseur-Bacle S, Roelandt JL, Noel C. Empowerment en santé mentale : recommandations et perspectives. Eur Psychiatry 2020. [DOI: 10.1016/j.eurpsy.2015.09.386] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
Abstract
L’Organisation mondiale de la santé (OMS) définit l’empowerment comme faisant « référence au niveau de choix, de décision, d’influence et de contrôle que les usagers des services de santé mentale peuvent exercer sur les événements de leur vie (…). La clé de l’empowerment se trouve dans la transformation des rapports de force et des relations de pouvoir entre les individus, les groupes, les services et les gouvernements » (Wallerstein, 2006). L’OMS mentionne également les aidants dans le Pacte européen pour la santé mentale et le bien-être (2004, 2007) : « L’empowerment des personnes avec un problème de santé mentale et des aidants sont des priorités pour la prochaine décennie ». Suite aux 4e rencontres internationales du centre collaborateur de l’OMS pour la recherche et la formation en santé mentale (CCOMS, Lille, France), 21 recommandations en faveur de l’empowerment des usagers des services de santé mentale et des aidants ont été définies (document disponibles : http://www.ccomssantementalelillefrance.org/?q=promotion-des-indicateurs-d%E2 %80 %99empowerment). Cette première étape est le fruit d’un travail conjoint entre usagers, aidants, élus et professionnels. Une seconde étape, en cours, consiste à associer des indicateurs d’empowerment permettant de dresser une cartographie de l’empowerment en santé mentale en Europe. Cette communication présentera le concept d’empowerment en santé mentale, la promotion de cette notion par l’OMS et les 21 recommandations. La discussion portera sur la question fondamentale suivante : comment promouvoir de manière concrète ces recommandations ?
Collapse
|
8
|
Pflieger R, Fayard E, Noel C, Nikitenko SI, Belmonte T. Molecular emissions in sonoluminescence spectra of water sonicated under Ar-based gas mixtures. Ultrason Sonochem 2019; 58:104637. [PMID: 31450313 DOI: 10.1016/j.ultsonch.2019.104637] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/10/2019] [Revised: 06/05/2019] [Accepted: 06/11/2019] [Indexed: 05/09/2023]
Abstract
Sonoluminescence (SL) spectroscopy is one of the very few ways to study the plasma formed in solutions submitted to ultrasound. Unfortunately, up to now only very limited emission bands were reported in SL spectra of aqueous solutions, moreover broad and badly resolved. It is shown here that by adding some N2 and/or CO2 in Ar, new molecular emissions (CN, N2 and CO) can be observed and that for some of them rovibronic temperatures can be derived. The paramount importance of Stark broadening in these emissions is underlined, together with the need for data on Stark parameters for molecular emissions.
Collapse
Affiliation(s)
- R Pflieger
- Institut de Chimie Séparative de Marcoule, ICSM UMR 5257 - CEA, CNRS, Univ Montpellier, ENSCM, Bagnols-sur-Cèze Cedex, France.
| | - E Fayard
- Institut de Chimie Séparative de Marcoule, ICSM UMR 5257 - CEA, CNRS, Univ Montpellier, ENSCM, Bagnols-sur-Cèze Cedex, France
| | - C Noel
- Université de Lorraine, Institut Jean Lamour, UMR CNRS 7198, Nancy, France
| | - S I Nikitenko
- Institut de Chimie Séparative de Marcoule, ICSM UMR 5257 - CEA, CNRS, Univ Montpellier, ENSCM, Bagnols-sur-Cèze Cedex, France
| | - T Belmonte
- Université de Lorraine, Institut Jean Lamour, UMR CNRS 7198, Nancy, France
| |
Collapse
|
9
|
Vantyghem MC, Chetboun M, Gmyr V, Jannin A, Espiard S, Le Mapihan K, Raverdy V, Delalleau N, Machuron F, Hubert T, Frimat M, Van Belle E, Hazzan M, Pigny P, Noel C, Caiazzo R, Kerr-Conte J, Pattou F. Ten-Year Outcome of Islet Alone or Islet After Kidney Transplantation in Type 1 Diabetes: A Prospective Parallel-Arm Cohort Study. Diabetes Care 2019; 42:2042-2049. [PMID: 31615852 DOI: 10.2337/dc19-0401] [Citation(s) in RCA: 56] [Impact Index Per Article: 11.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/25/2019] [Accepted: 08/03/2019] [Indexed: 02/03/2023]
Abstract
OBJECTIVE The long-term outcome of allogenic islet transplantation is unknown. The aim of this study was to evaluate the 10-year outcome of islet transplantation in patients with type 1 diabetes and hypoglycemia unawareness and/or a functioning kidney graft. RESEARCH DESIGN AND METHODS We enrolled in this prospective parallel-arm cohort study 28 subjects with type 1 diabetes who received islet transplantation either alone (ITA) or after a kidney graft (IAK). Islet transplantation consisted of two or three intraportal infusions of allogenic islets administered within (median [interquartile range]) 68 days (43-92). Immunosuppression was induced with interleukin-2 receptor antibodies and maintained with sirolimus and tacrolimus. The primary outcome was insulin independence with A1C ≤6.5% (48 mmol/mol). Secondary outcomes were patient and graft survival, severe hypoglycemic events (SHEs), metabolic control, and renal function. RESULTS The primary outcome was met by (Kaplan-Meier estimates [95% CI]) 39% (22-57) and 28% (13-45) of patients 5 and 10 years after islet transplantation, respectively. Graft function persisted in 82% (62-92) and 78% (57-89) of case subjects after 5 and 10 years, respectively, and was associated with improved glucose control, reduced need for exogenous insulin, and a marked decrease of SHEs. ITA and IAK had similar outcomes. Primary graft function, evaluated 1 month after the last islet infusion, was significantly associated with the duration of graft function and insulin independence. CONCLUSIONS Islet transplantation with the Edmonton protocol can provide 10-year markedly improved metabolic control without SHEs in three-quarters of patients with type 1 diabetes, kidney transplanted or not.
Collapse
Affiliation(s)
- Marie-Christine Vantyghem
- University of Lille, U1190-EGID, Lille, France .,Department of Endocrinology, Diabetology, and Metabolism, Centre Hospitalier Universitaire de Lille, Lille, France.,Inserm, U1190, Lille, France
| | - Mikael Chetboun
- University of Lille, U1190-EGID, Lille, France.,Inserm, U1190, Lille, France.,Department of General and Endocrine Surgery, Centre Hospitalier Universitaire de Lille, Lille, France
| | - Valéry Gmyr
- University of Lille, U1190-EGID, Lille, France.,Inserm, U1190, Lille, France
| | - Arnaud Jannin
- Department of Endocrinology, Diabetology, and Metabolism, Centre Hospitalier Universitaire de Lille, Lille, France
| | - Stéphanie Espiard
- Department of Endocrinology, Diabetology, and Metabolism, Centre Hospitalier Universitaire de Lille, Lille, France
| | - Kristell Le Mapihan
- Department of Endocrinology, Diabetology, and Metabolism, Centre Hospitalier Universitaire de Lille, Lille, France
| | - Violeta Raverdy
- University of Lille, U1190-EGID, Lille, France.,Inserm, U1190, Lille, France
| | - Nathalie Delalleau
- University of Lille, U1190-EGID, Lille, France.,Inserm, U1190, Lille, France
| | - François Machuron
- Department of Methodology, Biostatistics, and Data Management, Centre Hospitalier Universitaire de Lille, Lille, France
| | - Thomas Hubert
- University of Lille, U1190-EGID, Lille, France.,Inserm, U1190, Lille, France
| | - Marie Frimat
- Department of Nephrology, Centre Hospitalier Universitaire de Lille, Lille, France
| | - Eric Van Belle
- Department of Cardiology, Centre Hospitalier Universitaire de Lille, Lille, France
| | - Marc Hazzan
- Department of Nephrology, Centre Hospitalier Universitaire de Lille, Lille, France
| | - Pascal Pigny
- Department of Biochemistry and Hormonology, Centre Hospitalier Universitaire de Lille, Lille, France
| | - Christian Noel
- Department of Nephrology, Centre Hospitalier Universitaire de Lille, Lille, France
| | - Robert Caiazzo
- University of Lille, U1190-EGID, Lille, France.,Inserm, U1190, Lille, France.,Department of General and Endocrine Surgery, Centre Hospitalier Universitaire de Lille, Lille, France
| | - Julie Kerr-Conte
- University of Lille, U1190-EGID, Lille, France.,Inserm, U1190, Lille, France
| | - François Pattou
- University of Lille, U1190-EGID, Lille, France .,Inserm, U1190, Lille, France.,Department of General and Endocrine Surgery, Centre Hospitalier Universitaire de Lille, Lille, France
| | | |
Collapse
|
10
|
Artru F, Louvet A, Glowacki F, Bellati S, Frimat M, Gomis S, Castel H, Barthelon J, Lassailly G, Dharancy S, Noel C, Hazzan M, Mathurin P. The prognostic impact of cirrhosis on patients receiving maintenance haemodialysis. Aliment Pharmacol Ther 2019; 50:75-83. [PMID: 31087566 DOI: 10.1111/apt.15279] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/13/2018] [Revised: 10/01/2018] [Accepted: 04/01/2019] [Indexed: 12/13/2022]
Abstract
BACKGROUND Further study is needed on the prognostic impact of cirrhosis on haemodialysis patients. AIM To evaluate cirrhosis' impact according to severity on survival and to provide therapeutic guidelines for haemodialysis cirrhotic patients. METHODS Patients with end-stage renal failure treated with haemodialysis were included retrospectively from 01/01/2000 to 31/12/2004 and prospectively from 01/01/2005 to 31/12/2014 in our French Region. Clinical data, presence of cirrhosis and its severity were recorded at the beginning of haemodialysis. The primary endpoint was 2-year survival. RESULTS Seven thousand three hundred and fifty-four patients (96%) without cirrhosis and 304 patients (4%) with cirrhosis were included. Two-year survival in noncirrhotic patients was higher than in cirrhotic patients (71.7% vs 54.4%, P < 0.0001). Patients with decompensated cirrhosis had a worse 2-year outcome (44.1%) as compared to compensated cirrhotic (62.8%, P = 0.002) and noncirrhotic patients (71.7%, P < 0.0001). Compensated and decompensated cirrhosis were independent predictive factors of 2-year mortality. In sensitivity analysis restricted to cirrhotic patients, 2-year survival of Child-Pugh A patients was higher than in Child-Pugh B and C patients (65.5% vs 27.7% vs 0%, P < 0.0001). Development of predictive models based either on severity scores (MELD and Child-Pugh) and extrahepatic comorbidities allowed correct classification of around 70% of patients in terms of mortality and may help to better stratify mortality risk in this population. CONCLUSIONS Cirrhosis is independently associated with mortality in haemodialysis patients. Patients with severe cirrhosis have a poor 2-year outcome. Severity of cirrhosis and presence of extrahepatic comorbidities should be considered when deciding to initiate renal replacement therapy.
Collapse
Affiliation(s)
- Florent Artru
- Hôpital Claude Huriez, Services des Maladies de l'Appareil Digestif, CHRU Lille, and Unité INSERM 995, Lille, France
| | - Alexandre Louvet
- Hôpital Claude Huriez, Services des Maladies de l'Appareil Digestif, CHRU Lille, and Unité INSERM 995, Lille, France
| | - François Glowacki
- Hôpital Claude Huriez, Service de Néphrologie et de dialyse CHRU Lille, Lille, France
| | - Sara Bellati
- Hôpital Claude Huriez, Services des Maladies de l'Appareil Digestif, CHRU Lille, and Unité INSERM 995, Lille, France
| | - Marie Frimat
- Hôpital Claude Huriez, Service de Néphrologie et de dialyse CHRU Lille, Lille, France
| | - Sebastien Gomis
- Hôpital Claude Huriez, Service de Néphrologie et de dialyse CHRU Lille, Lille, France
| | - Hélène Castel
- Hôpital Claude Huriez, Services des Maladies de l'Appareil Digestif, CHRU Lille, and Unité INSERM 995, Lille, France
| | - Justine Barthelon
- Hôpital Claude Huriez, Services des Maladies de l'Appareil Digestif, CHRU Lille, and Unité INSERM 995, Lille, France
| | - Guillaume Lassailly
- Hôpital Claude Huriez, Services des Maladies de l'Appareil Digestif, CHRU Lille, and Unité INSERM 995, Lille, France
| | - Sebastien Dharancy
- Hôpital Claude Huriez, Services des Maladies de l'Appareil Digestif, CHRU Lille, and Unité INSERM 995, Lille, France
| | - Christian Noel
- Hôpital Claude Huriez, Service de Néphrologie et de dialyse CHRU Lille, Lille, France
| | - Marc Hazzan
- Hôpital Claude Huriez, Service de Néphrologie et de dialyse CHRU Lille, Lille, France
| | - Philippe Mathurin
- Hôpital Claude Huriez, Services des Maladies de l'Appareil Digestif, CHRU Lille, and Unité INSERM 995, Lille, France
| |
Collapse
|
11
|
Knott V, Payumo M, Hyde M, Nelson R, Duncan B, Devlin M, Noel C, Abozmal A, Salle SDL. The Effects of Transcranial Alternating Current Stimulation on the Auditory Steady-State Response and its Association with Schizotypy. Brain Stimul 2019. [DOI: 10.1016/j.brs.2018.12.659] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
12
|
Moseley M, Murff H, Powers J, Murff H, Salloum N, Noel C, Misra S. DEVELOPING A WHOLE HEALTH GERI-PACT: WHAT MATTERS MOST. Innov Aging 2018. [DOI: 10.1093/geroni/igy023.2975] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- M Moseley
- Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee, United States
| | - H Murff
- Geriatric Research Education and Clinical Center (GRECC), Department of Veterans Affairs, Tennessee Valley Healthcare System
| | - J Powers
- Geriatric Research Education and Clinical Center (GRECC), Department of Veterans Affairs, Tennessee Valley Healthcare System
| | - Harvey Murff
- Geriatric Research Education and Clinical Center (GRECC), Department of Veterans Affairs, Tennessee Valley Healthcare System
| | - N Salloum
- Department of Veterans Affairs, Tennessee Valley Healthcare System
| | - C Noel
- Department of Veterans Affairs, Tennessee Valley Healthcare System
| | - S Misra
- Geriatric Research Education and Clinical Center (GRECC), Department of Veterans Affairs, Tennessee Valley Healthcare System
| |
Collapse
|
13
|
Segaud N, Legroux I, Hazzan M, Noel C, Cortet B. Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort. Osteoporos Int 2018; 29:1165-1175. [PMID: 29500526 DOI: 10.1007/s00198-018-4383-2] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/15/2017] [Accepted: 01/04/2018] [Indexed: 12/18/2022]
Abstract
INTRODUCTION In renal transplant patients, bone loss may be related to the drugs patients are taking but also to their past history of chronic kidney disease. The purpose of this study was to assess changes in BMD 2 years after an initial assessment (performed 9 months post transplantation) and the factors associated with these changes. METHODS This longitudinal study included patients who had undergone a renal transplantation between 2005 and 2011, and who were followed up at the Lille Regional University Hospital. Patients were included if they had a first bone evaluation (including bone densitometry, spine X-rays and biological assessment) and at least another BMD assessment. The first assessment was performed on average 9 months post transplantation. A second assessment was performed at 2 years. RESULTS Two hundred fifty-nine out of 366 patients satisfied the inclusion criteria. The population included 96 women. Mean age at transplantation was 49.7 ± 12.1 years. Mean duration of dialysis was 3.2 ± 3.3 years. For 75 patients (29.0%), corticosteroid treatment was discontinued 7 days after transplantation without subsequent resumption during follow-up. Vertebral fractures assessed by X-rays at baseline were found in 28 patients (10.8%). According to the WHO classification, 106 patients (40.9%) patients had osteoporosis and 111 patients (42.8%) had osteopenia at the first assessment. Oral bisphosphonates were prescribed for 95 patients. The decision to prescribe bisphosphonates was taken jointly by rheumatologists and nephrologists based on BMD assessment, past history of fracture and corticosteroid management. In all patients, BMD gains at the second evaluation (2.2 ± 0.79 years) compared with baseline were significant (3.9 ± 6.6, 2.6% ± 7.6, 3.0 ± 7.2% at the lumbar spine, femoral neck and total hip respectively; p < 0.0001). The difference in gain between bisphosphonate-treated and untreated patients was significant (+ 5.0 ± 0.8% (p < 0.0001), + 2.5 ± 1.0% (p = 0.01) and + 2.7 ± 0.9% (p < 0.01) at the lumbar spine, femoral neck and total hip respectively. The patients who benefited early corticosteroid discontinuation had higher gains in BMD at the lumbar spine (+ 2.1 ± 0.9%; p = 0.02) and total hip (+ 2.0 ± 1.0%; p = 0.04) compared to those for whom corticosteroid therapy was maintained. Stepwise regression analysis (patients without bisphosphonates) showed associations between change in BMD (femoral neck) and duration of corticosteroid therapy, bone alkaline phosphatase level at baseline, and absence of vertebral fracture. No correlation was found between change in BMD and duration of dialysis or renal function. CONCLUSION Kidney transplant recipients have an increased risk of bone fragility in the year following transplantation. Bisphosphonates and early corticosteroid discontinuation can improve BMD.
Collapse
Affiliation(s)
- N Segaud
- Service de médecine interne, CH Armentières, F-59280, Armentières, France.
- Service de Rhumatologie, CHU Lille, F-59000, Lille, France.
| | - I Legroux
- Service de Rhumatologie, CHU Lille, F-59000, Lille, France
- EA 4490 - PMOI - Physiopathologie des Maladies Osseuses Inflammatoires, Université de Lille, F-59000, Lille, France
| | - M Hazzan
- Service de Néphrologie, CHU Lille, F-59000, Lille, France
| | - C Noel
- Service de Néphrologie, CHU Lille, F-59000, Lille, France
| | - B Cortet
- Service de Rhumatologie, CHU Lille, F-59000, Lille, France
- EA 4490 - PMOI - Physiopathologie des Maladies Osseuses Inflammatoires, Université de Lille, F-59000, Lille, France
| |
Collapse
|
14
|
Benomar K, Chetboun M, Espiard S, Jannin A, Le Mapihan K, Gmyr V, Caiazzo R, Torres F, Raverdy V, Bonner C, D'Herbomez M, Pigny P, Noel C, Kerr-Conte J, Pattou F, Vantyghem MC. Purity of islet preparations and 5-year metabolic outcome of allogenic islet transplantation. Am J Transplant 2018; 18:945-951. [PMID: 28941330 DOI: 10.1111/ajt.14514] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2017] [Revised: 08/23/2017] [Accepted: 09/04/2017] [Indexed: 01/25/2023]
Abstract
In allogenic islet transplantation (IT), high purity of islet preparations and low contamination by nonislet cells are generally favored. The aim of the present study was to analyze the relation between the purity of transplanted preparations and graft function during 5 years post-IT. Twenty-four patients with type 1 diabetes, followed for 5 years after IT, were enrolled. Metabolic parameters and daily insulin requirements were compared between patients who received islet preparations with a mean purity <50% (LOW purity) or ≥50% (HIGH purity). We also analyzed blood levels of carbohydrate antigen 19-9 (CA 19-9)-a biomarker of pancreatic ductal cells-and glucagon, before and after IT. At 5 years, mean hemoglobin A1c (HbA1c levels) (P = .01) and daily insulin requirements (P = .03) were lower in the LOW purity group. Insulin independence was more frequent in the LOW purity group (P < .05). CA19-9 and glucagon levels increased post-IT (P < .0001) and were inversely correlated with the degree of purity. Overall, our results suggest that nonislet cells have a beneficial effect on long-term islet graft function, possibly through ductal-to-endocrine cell differentiation. ClinicalTrial.gov NCT00446264 and NCT01123187.
Collapse
Affiliation(s)
- K Benomar
- Department of Endocrinology and Metabolism, CHRU Lille, Lille, France.,UMR 1190, Translational Research in Diabetes INSERM, Lille, France.,EGID (European Genomic Institute for Diabetes), Univ Lille, Lille, France
| | - M Chetboun
- UMR 1190, Translational Research in Diabetes INSERM, Lille, France.,EGID (European Genomic Institute for Diabetes), Univ Lille, Lille, France.,Department of Endocrine Surgery, CHRU Lille, Lille, France
| | - S Espiard
- Department of Endocrinology and Metabolism, CHRU Lille, Lille, France
| | - A Jannin
- Department of Endocrinology and Metabolism, CHRU Lille, Lille, France
| | - K Le Mapihan
- Department of Endocrinology and Metabolism, CHRU Lille, Lille, France
| | - V Gmyr
- UMR 1190, Translational Research in Diabetes INSERM, Lille, France.,EGID (European Genomic Institute for Diabetes), Univ Lille, Lille, France
| | - R Caiazzo
- UMR 1190, Translational Research in Diabetes INSERM, Lille, France.,EGID (European Genomic Institute for Diabetes), Univ Lille, Lille, France.,Department of Endocrine Surgery, CHRU Lille, Lille, France
| | - F Torres
- UMR 1190, Translational Research in Diabetes INSERM, Lille, France.,EGID (European Genomic Institute for Diabetes), Univ Lille, Lille, France.,Department of Endocrine Surgery, CHRU Lille, Lille, France
| | - V Raverdy
- UMR 1190, Translational Research in Diabetes INSERM, Lille, France.,EGID (European Genomic Institute for Diabetes), Univ Lille, Lille, France.,Department of Endocrine Surgery, CHRU Lille, Lille, France
| | - C Bonner
- UMR 1190, Translational Research in Diabetes INSERM, Lille, France.,EGID (European Genomic Institute for Diabetes), Univ Lille, Lille, France
| | - M D'Herbomez
- Department of Biology, CHRU Lille, Lille, France
| | - P Pigny
- Department of Biology, CHRU Lille, Lille, France
| | - C Noel
- Department of Nephrology and Transplantation, CHRU Lille, Lille, France
| | - J Kerr-Conte
- UMR 1190, Translational Research in Diabetes INSERM, Lille, France.,EGID (European Genomic Institute for Diabetes), Univ Lille, Lille, France
| | - F Pattou
- UMR 1190, Translational Research in Diabetes INSERM, Lille, France.,EGID (European Genomic Institute for Diabetes), Univ Lille, Lille, France.,Department of Endocrine Surgery, CHRU Lille, Lille, France
| | - M C Vantyghem
- Department of Endocrinology and Metabolism, CHRU Lille, Lille, France.,UMR 1190, Translational Research in Diabetes INSERM, Lille, France.,EGID (European Genomic Institute for Diabetes), Univ Lille, Lille, France
| |
Collapse
|
15
|
Neff KJ, Baud G, Raverdy V, Caiazzo R, Verkindt H, Noel C, le Roux CW, Pattou F. Renal Function and Remission of Hypertension After Bariatric Surgery: a 5-Year Prospective Cohort Study. Obes Surg 2017; 27:613-619. [PMID: 27628054 DOI: 10.1007/s11695-016-2333-7] [Citation(s) in RCA: 36] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
PURPOSE This study examines the effect of Roux-en-Y gastric bypass (RYGB) and laparoscopic adjustable gastric banding (LAGB) on renal function for at least 5 years post-operatively in a tertiary referral center for bariatric surgery. MATERIALS AND METHODS This prospective cohort study of patients undergoing RYGB and LAGB measured renal function, blood pressure, and diabetes status pre-operatively and then 1 and 5 years post-operatively. Renal function was assessed using the Modification of Diet in Renal Disease (MDRD), Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI), and Cockcroft-Gault formulae. Hypertension and diabetes were defined by the European Society of Hypertension and European Society of Cardiology joint guidelines and American Diabetes Association guidelines, respectively. A sub-group who had completed 10 years post-operative follow-up was also included. RESULTS Estimated glomerular filtration rate (eGFR) increased over 5 years after RYGB (N = 190; 94 ± 2 mL/min/1.73 m2 to 102 ± 22 mL/min/1.73 m2, p = 0.01) and LAGB (N = 271; 88 ± 1 to 93 ± 22 mL/min/1.73 m2, p = 0.02). In a sub-group with up to 10 years post-operative date, this trend was maintained. In patients with renal impairment, eGFR improved over 5 years (52 ± 2 to 68 ± 7 mL/min/1.73 m2, p = 0.01). Remission of hypertension was greater after RYGB than LAGB at 1 year (32 vs. 16 %, p = 0.008) and at 5 years post-operatively (23 vs. 11 %, p = 0.02). CONCLUSIONS Bariatric surgery stabilizes eGFR post-operatively for at least 5 years. In a sub-group with renal impairment, eGFR is increased in the first post-operative year and this is maintained for up to 5 years. RYGB is an effective procedure in achieving blood pressure control.
Collapse
Affiliation(s)
- Karl J Neff
- Diabetic Complication Research Centre, UCD Conway Institute, School of Medicine, University College Dublin, Belfield, Dublin 4, Ireland
| | - Gregory Baud
- General and Endocrine Surgery, Lille University Hospital, Lille, France.,Inserm U 1190, European Genomic Institute for Diabetes, Lille University, Lille, France
| | - Violeta Raverdy
- General and Endocrine Surgery, Lille University Hospital, Lille, France.,Inserm U 1190, European Genomic Institute for Diabetes, Lille University, Lille, France
| | - Robert Caiazzo
- General and Endocrine Surgery, Lille University Hospital, Lille, France.,Inserm U 1190, European Genomic Institute for Diabetes, Lille University, Lille, France
| | - Helene Verkindt
- General and Endocrine Surgery, Lille University Hospital, Lille, France.,Inserm U 1190, European Genomic Institute for Diabetes, Lille University, Lille, France
| | | | - Carel W le Roux
- Diabetic Complication Research Centre, UCD Conway Institute, School of Medicine, University College Dublin, Belfield, Dublin 4, Ireland.,Gastrosurgical Laboratory, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - François Pattou
- General and Endocrine Surgery, Lille University Hospital, Lille, France. .,Inserm U 1190, European Genomic Institute for Diabetes, Lille University, Lille, France.
| |
Collapse
|
16
|
Belaiche S, Décaudin B, Dharancy S, Gautier S, Noel C, Odou P, Hazzan M. Factors associated with the variability of calcineurin inhibitor blood levels in kidney recipients grafted for more than 1 year. Fundam Clin Pharmacol 2017; 32:88-97. [DOI: 10.1111/fcp.12328] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2017] [Revised: 09/06/2017] [Accepted: 10/10/2017] [Indexed: 11/30/2022]
Affiliation(s)
- Stéphanie Belaiche
- Institut de pharmacie; CHU Lille; F-59000 Lille France
- EA 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées; Université Lille; F-59000 Lille France
| | - Bertrand Décaudin
- Institut de pharmacie; CHU Lille; F-59000 Lille France
- EA 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées; Université Lille; F-59000 Lille France
| | - Sébastien Dharancy
- Service des Maladies de l'appareil Digestif et de la Nutrition; CHU Lille; F-59000 Lille France
- Inserm U995 - LIRIC - Lille Inflammation Research International Center; Université Lille; F-59000 Lille France
| | - Sophie Gautier
- Département de pharmacologie; CHU Lille; F-59000 Lille France
- Inserm, U1171; Université Lille; F-59000 Lille France
| | - Christian Noel
- Service de Néphrologie; CHU Lille; F-59000 Lille France
- Inserm U995 - LIRIC - Lille Inflammation Research International Center; Université Lille; F-59000 Lille France
| | - Pascal Odou
- Institut de pharmacie; CHU Lille; F-59000 Lille France
- EA 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées; Université Lille; F-59000 Lille France
| | - Marc Hazzan
- Service de Néphrologie; CHU Lille; F-59000 Lille France
- Inserm U995 - LIRIC - Lille Inflammation Research International Center; Université Lille; F-59000 Lille France
| |
Collapse
|
17
|
Gagnon M, Noel C, Cardinal M, Tetu C, Cavallé-Garrido T, Vaujois L, Bigras J, Roy-Lacroix M, Poder T, Vanasse A, Marelli A, Dallaire F. LOW YIELD OF FETAL ECHOCARDIOGRAPHY WHEN NO SUSPICION OF HEART DISEASE BY REFERRING OBSTETRICIAN. Can J Cardiol 2017. [DOI: 10.1016/j.cjca.2017.07.195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
18
|
Bouderlique É, Lionet A, Provot F, Dekeyser T, Zaworski J, Lessore De Sainte Foy C, Noel C. Expérience de la rhéophérèse en traitement adjuvant de la calciphylaxie. Nephrol Ther 2017. [DOI: 10.1016/j.nephro.2017.08.117] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
19
|
Guise C, Hazzan M, Azar R, Bourdon F, Guincestre T, Lemoine C, Maisonneuve N, Noel C, Glowacki F. La précarité influence-t-elle l’accès à la greffe ? Nephrol Ther 2017. [DOI: 10.1016/j.nephro.2017.08.061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
20
|
Saint-Jacques C, Gnemmi V, Haymann J, Letavernier E, Noel C, Frochot V, Daudon M, Lionet A. Description des micro-calcifications découvertes sur ponction-biopsie rénale de reins natifs. Nephrol Ther 2017. [DOI: 10.1016/j.nephro.2017.08.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
21
|
Lenain R, Georges L, Hamroun A, Noel C, Provot F. Tubulopathie proximale induite par perfusion d’acides aminés dans la radiothérapie interne vectorisée par 177Lu-DOTA0-Tyr3-octréotate. Nephrol Ther 2017. [DOI: 10.1016/j.nephro.2017.08.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
22
|
Belaiche S, Décaudin B, Dharancy S, Noel C, Odou P, Hazzan M. Factors relevant to medication non-adherence in kidney transplant: a systematic review. Int J Clin Pharm 2017; 39:582-593. [PMID: 28374343 DOI: 10.1007/s11096-017-0436-4] [Citation(s) in RCA: 62] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2016] [Accepted: 02/06/2017] [Indexed: 01/14/2023]
Abstract
Background Medication non-adherence is a major issue after transplant that can lead to misdiagnosis, rejection, poor health affecting quality of life, graft loss or death. Several estimations of adherence and related factors have previously been described but conclusions leave doubt as to the most accurate assessment method. Aim of the review To identify the factors most relevant to medication non-adherence in kidney transplant in current clinical practice. Method This systematic review is registered in the PROSPERO data base and follows the Prisma checklist. Articles in English in three databases from January 2009 to December 2014 were analysed. A synthesis was made to target adherence assessment methods, their prevalence and significance. Results Thirty-seven studies were analysed rates of non-adherence fluctuating from 1.6 to 96%. Assessment methods varied from one study to another, although self-reports were mainly used. It appears that youth (≤50 years old), male, low social support, unemployment, low education, ≥3 months post graft, living donor, ≥6 comorbidities, ≥5 drugs/d, ≥2 intakes/d, negative beliefs, negative behavior, depression and anxiety were the factors significantly related to non-adherence. Conclusion As there are no established guidelines, consideration should be given to more than one approach to identify medication non-adherence although self-reports should remain the cornerstone of adherence assessment.
Collapse
Affiliation(s)
- Stephanie Belaiche
- Institut de pharmacie, CHU Lille, 59000, Lille, France. .,EA 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, Univ. Lille, 59000, Lille, France.
| | - Bertrand Décaudin
- Institut de pharmacie, CHU Lille, 59000, Lille, France.,EA 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, Univ. Lille, 59000, Lille, France
| | - Sébastien Dharancy
- Service des Maladies de l'appareil digestif et de la Nutrition, CHU Lille, 59000, Lille, France.,Inserm U995 - LIRIC - Lille Inflammation Research International Center, Univ. Lille, 59000, Lille, France
| | - Christian Noel
- Service de Néphrologie, CHU Lille, 59000, Lille, France.,Inserm U995 - LIRIC - Lille Inflammation Research International Center, Univ. Lille, 59000, Lille, France
| | - Pascal Odou
- Institut de pharmacie, CHU Lille, 59000, Lille, France.,EA 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, Univ. Lille, 59000, Lille, France
| | - Marc Hazzan
- Service de Néphrologie, CHU Lille, 59000, Lille, France.,Inserm U995 - LIRIC - Lille Inflammation Research International Center, Univ. Lille, 59000, Lille, France
| |
Collapse
|
23
|
Cai B, Dolly S, Chen H, Anastasio M, Yaddanapudi S, Sun B, Noel C, Goddu S, Mutic S, Li H. TH-CD-304-03: A Novel and Intelligent Strategy for Automated On-Board Imager Quality Assurance. Med Phys 2016. [DOI: 10.1118/1.4926209] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
24
|
Noel C, Cirbus J, Han J. 127 Emergency Department Interventions and Their Effect on Delirium's Natural Course: The Folly May Be in the Foley. Ann Emerg Med 2016. [DOI: 10.1016/j.annemergmed.2016.08.139] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
25
|
Elaidi R, Vano Y, Aide N, Fournier L, Deandreis D, Tenenbaum F, Lebtahi R, De Clermont-Galleran H, Albiges L, Escudier B, Joly F, Alexandre J, Bernardini M, Baron S, Arfi-Rouche J, Noel C, Braychenko E, O'Quigley J, Medioni J, Oudard S. Phase I/II dose-finding, safety and efficacy study of radium-223 dichloride in renal cell carcinoma patients with bone metastases. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw373.80] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
26
|
Pottier N, Frimat M, Lionet A, Noel C, Broly F, Glowacki F. Apports des techniques de séquençage haut débit dans le diagnostic moléculaire des néphropathies glomérulaires héréditaires. Nephrol Ther 2016. [DOI: 10.1016/j.nephro.2016.07.209] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
27
|
Frimat M, Decambron M, Lebas C, Moktefi A, Lemaitre L, Gnemmi V, Sautenet B, Glowacki F, Subtil D, Jourdain M, Rigouzzo A, Brocheriou I, Halimi JM, Rondeau E, Noel C, Provôt F, Hertig A. Renal Cortical Necrosis in Postpartum Hemorrhage: A Case Series. Am J Kidney Dis 2016; 68:50-7. [DOI: 10.1053/j.ajkd.2015.11.022] [Citation(s) in RCA: 56] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2015] [Accepted: 11/29/2015] [Indexed: 11/11/2022]
|
28
|
Vasseur AS, Hazzan M, Lemaitre L, Kilani M, Anglicheau D, Caillard-Ohlmann S, Choukroun G, Godin M, hurault de ligny B, Mousson C, Merville P, Vigneau C, Glowacki F, Noel C, Frimat M. MP739TRANSPLANT RENAL ARTERY STENOSIS : A CASE SERIES. Nephrol Dial Transplant 2016. [DOI: 10.1093/ndt/gfw200.63] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
29
|
Foster GE, Deng Z, Boulet LM, Mehta PK, Wei J, Fan Z, Dharmakumar R, Noel C, Merz B, Li D, Nelson MD. Changes in left ventricular function and coronary blood flow velocity during isocapnic hypoxia: A cardiac magnetic resonance imaging study. J Cardiovasc Magn Reson 2016. [PMCID: PMC5032778 DOI: 10.1186/1532-429x-18-s1-p126] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
30
|
Santanam L, Noel C, Wan H, Kashani R, Rankine L, Mazur T, Goddu S, Wooten H, Yaddanapudi S, Green O, Parikh P, Mutic S, Olsen J. Adequacy of Gating Margins for Abdominal Tumors of Patients Treated With Real-Time MR Guided Radiation Therapy. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.521] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
31
|
Leroy C, Rigot JM, Leroy M, Decanter C, Le Mapihan K, Parent AS, Le Guillou AC, Yakoub-Agha I, Dharancy S, Noel C, Vantyghem MC. Immunosuppressive drugs and fertility. Orphanet J Rare Dis 2015; 10:136. [PMID: 26490561 PMCID: PMC4618138 DOI: 10.1186/s13023-015-0332-8] [Citation(s) in RCA: 108] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2015] [Accepted: 08/30/2015] [Indexed: 12/16/2022] Open
Abstract
Immunosuppressive drugs are used in the treatment of inflammatory and autoimmune diseases, as well as in transplantation. Frequently prescribed in young people, these treatments may have deleterious effects on fertility, pregnancy outcomes and the unborn child. This review aims to summarize the main gonadal side effects of immunosuppressants, to detail the effects on fertility and pregnancy of each class of drug, and to provide recommendations on the management of patients who are seen prior to starting or who are already receiving immunosuppressive treatment, allowing them in due course to bear children. The recommendations for use are established with a rather low level of proof, which needs to be taken into account in the patient management. Methotrexate, mycophenolate, and le- and teri-flunomide, cyclophosphamide, mitoxanthrone are contraindicated if pregnancy is desired due to their teratogenic effects, as well as gonadotoxic effects in the case of cyclophosphamide. Anti-TNF-alpha and mTOR-inhibitors are to be used cautiously if pregnancy is desired, since experience using these drugs is still relatively scarce. Azathioprine, glucocorticoids, mesalazine, anticalcineurins such as cyclosporine and tacrolimus, ß-interferon, glatiramer-acetate and chloroquine can be used during pregnancy, bearing in mind however that side effects may still occur. Experience is limited concerning natalizumab, fingolimod, dimethyl-fumarate and induction treatments. Conclusion: At the time of prescription, patients must be informed of the possible consequences of immunosuppressants on fertility and of the need for contraception. Pregnancy must be planned and the treatment modified if necessary in a pre-conception time period adapted to the half-life of the drug, imperatively in relation with the prescriber of the immunosuppressive drugs.
Collapse
Affiliation(s)
- Clara Leroy
- Endocrinology and Metabolism, Hôpital Huriez, Lille University Hospital, 59037, Lille Cedex, France.
- Andrology, Hôpital Calmette, Lille University Hospital, 59037, Lille Cedex, France.
| | - Jean-Marc Rigot
- Andrology, Hôpital Calmette, Lille University Hospital, 59037, Lille Cedex, France.
| | - Maryse Leroy
- Gynaecology -Obstetrics, Hôpital Jeanne de Flandres, Lille University Hospital, 59037, Lille Cedex, France.
| | - Christine Decanter
- Endocrine Gynaecology, Hôpital Jeanne de Flandres, Lille University Hospital, 59037, Lille Cedex, France.
| | - Kristell Le Mapihan
- Endocrinology and Metabolism, Hôpital Huriez, Lille University Hospital, 59037, Lille Cedex, France.
| | - Anne-Sophie Parent
- Endocrinology and Metabolism, Hôpital Huriez, Lille University Hospital, 59037, Lille Cedex, France.
| | - Anne-Claire Le Guillou
- Endocrinology and Metabolism, Hôpital Huriez, Lille University Hospital, 59037, Lille Cedex, France.
| | - Ibrahim Yakoub-Agha
- Hematology, Hôpital Huriez, Lille University Hospital, 59037, Lille Cedex, France.
| | - Sébastien Dharancy
- Liver Diseases and Gastroenterology, Hôpital Huriez, Lille University Hospital, 59037, Lille Cedex, France.
| | - Christian Noel
- Nephrology Hôpital Huriez, Lille University Hospital, 59037, Lille Cedex, France.
| | - Marie-Christine Vantyghem
- Endocrinology and Metabolism, Hôpital Huriez, Lille University Hospital, 59037, Lille Cedex, France.
- InsermU859 Biotherapies of Diabetes, Lille University Hospital, 59037, Lille Cedex, France.
| |
Collapse
|
32
|
Lebas C, Vilaine E, Lessore De Sainte Foy C, Lemaitre L, Verine J, Buob D, Noel C, Frimat M, Vrigneaud L, Vanhille P. Atteinte rénale révélant une hémoglobinurie paroxystique nocturne : à propos de trois cas. Nephrol Ther 2015. [DOI: 10.1016/j.nephro.2015.07.335] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
33
|
Dolly S, Cai B, Chen H, Anastasio M, Tan J, Sun B, Yaddanapudi S, Noel C, Goddu S, Mutic S, Li H. SU-C-304-04: A Compact Modular Computational Platform for Automated On-Board Imager Quality Assurance. Med Phys 2015. [DOI: 10.1118/1.4923792] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
34
|
Harry T, Yaddanapudi S, Cai B, Goddu S, Noel C, Mutic S, Pawlicki T. SU-E-T-269: Differential Hazard Analysis For Conventional And New Linac Acceptance Testing Procedures. Med Phys 2015. [DOI: 10.1118/1.4924631] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
35
|
Cai B, Yaddanapudi S, Sun B, Li H, Noel C, Mutic S, Goddu S. SU-E-T-775: Use of Electronic Portal Imaging Device (EPID) for Quality Assurance (QA) of Electron Beams On Varian Truebeam System. Med Phys 2015. [DOI: 10.1118/1.4925139] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
36
|
Yaddanapudi S, Cai B, Sun B, Noel C, Goddu S, Mutic S. SU-E-T-781: Using An Electronic Portal Imaging Device (EPID) for Correlating Linac Photon Beam Energies. Med Phys 2015. [DOI: 10.1118/1.4925145] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
37
|
Yaddanapudi S, Cai B, Harry T, Sun B, Li H, Noel C, Goddu S, Pawlicki T, Mutic S. SU-C-304-02: Robust and Efficient Process for Acceptance Testing of Varian TrueBeam Linacs Using An Electronic Portal Imaging Device (EPID). Med Phys 2015. [DOI: 10.1118/1.4923790] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
38
|
Segaud N, Legroux I, Hazzan M, Noel C, Cortet B. SAT0296 Bone Mineral Density Changes After Kidney Transplantation. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.2219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
39
|
Strubi-Vuillaume I, Carlier V, Obeuf C, Vasseur F, Maury JC, Maboudou P, Mangalaboyi J, Durocher A, Launay D, Noel C, Brousseau T. Gentle blood aspiration and tube cushioning reduce pneumatic tube system interference in lactate dehydrogenase assays. Ann Clin Biochem 2015; 53:295-7. [DOI: 10.1177/0004563215586600] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/21/2015] [Indexed: 11/16/2022]
Abstract
Background Use of a hospital pneumatic tube system may be associated with measurement errors. Methods A venous blood sample was collected from 79 patients into a pair of lithium heparin tubes; one tube was sent to the laboratory by porter and the other was sent via the pneumatic tube system. Plasma lactate dehydrogenase concentrations were then assayed. Results Lactate dehydrogenase concentrations were overestimated (median bias: 18.8%) when evacuated vacuum lithium heparin tubes were sent by pneumatic tube system. This bias was reduced by bubble-wrapping the standard lithium heparin tube or using Monovette lithium heparin tubes in aspiration mode (median bias: +8.7% and −0.3%, respectively). Conclusions Cushioning and aspiration-mode sampling may limit pneumatic tube system-associated overestimation of lactate dehydrogenase concentrations.
Collapse
Affiliation(s)
- Isabelle Strubi-Vuillaume
- UF 8832 – Biochimie Automatisée, Pôle de Biologie Pathologie Génétique, CHRU de Lille, Lille, France
| | - Valentine Carlier
- UF 8832 – Biochimie Automatisée, Pôle de Biologie Pathologie Génétique, CHRU de Lille, Lille, France
| | - Catherine Obeuf
- UF 8832 – Biochimie Automatisée, Pôle de Biologie Pathologie Génétique, CHRU de Lille, Lille, France
| | - Francis Vasseur
- EA 2694, Unité de Biostatistique, Université Lille Nord de France, Lille, France
| | - J-Claude Maury
- UF 8832 – Biochimie Automatisée, Pôle de Biologie Pathologie Génétique, CHRU de Lille, Lille, France
| | - Patrice Maboudou
- UF 8832 – Biochimie Automatisée, Pôle de Biologie Pathologie Génétique, CHRU de Lille, Lille, France
| | - Jacques Mangalaboyi
- Service de Réanimation, Hôpital Roger Salengro, CHRU de Lille, Lille, France
| | - Alain Durocher
- Service de Réanimation, Hôpital Calmette, CHRU de Lille, Lille, France
| | - David Launay
- Service de Médecine Interne, Hôpital Huriez, CHRU de Lille, Lille, France
| | - Christian Noel
- Service de Néphrologie, Hôpital Huriez, CHRU de Lille, Lille, France
| | - Thierry Brousseau
- UF 8832 – Biochimie Automatisée, Pôle de Biologie Pathologie Génétique, CHRU de Lille, Lille, France
| |
Collapse
|
40
|
Sebert JL, Fardellone P, Noel C, Cohen-Solal M, Bellony R, Marie A, Fournier A. Bone biopsy studies in the diagnosis and treatment of renal osteodystrophy. Contrib Nephrol 2015; 64:49-57. [PMID: 3180824 DOI: 10.1159/000415727] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Affiliation(s)
- J L Sebert
- Service de Nephrologie, Centre Hospitalier Universitaire, Amiens, France
| | | | | | | | | | | | | |
Collapse
|
41
|
Bayat S, Macher MA, Couchoud C, Bayer F, Lassalle M, Villar E, Caillé Y, Mercier S, Joyeux V, Noel C, Kessler M, Jacquelinet C. Individual and regional factors of access to the renal transplant waiting list in france in a cohort of dialyzed patients. Am J Transplant 2015; 15:1050-60. [PMID: 25758788 DOI: 10.1111/ajt.13095] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2014] [Revised: 10/10/2014] [Accepted: 11/01/2014] [Indexed: 01/25/2023]
Abstract
Several studies have investigated geographical variations in access to renal transplant waiting lists, but none has assessed the impact on these variations of factors at both the patient and geographic levels. The objective of our study was to identify medical and non-medical factors at both these levels associated with these geographical variations in waiting-list placement in France. We included all incident patients aged 18-80 years in 11 French regions who started dialysis between January 1, 2006, and December 31, 2008. Both a multilevel Cox model with shared frailty and a competing risks model were used for the analyses. At the patient level, old age, comorbidities, diabetic nephropathy, non-autonomous first dialysis, and female gender were the major determinants of a lower probability of being waitlisted. At the regional level, the only factor associated with this probability was an increase in the number of patients on the waiting list from 2005 to 2009. This finding supports a slight but significant impact of a regional organ shortage on waitlisting practices. Our findings demonstrate that patients' age has a major impact on waitlisting practices, even for patients with no comorbidity or disability, whose survival would likely be improved by transplantation compared with dialysis.
Collapse
Affiliation(s)
- S Bayat
- Département d'Epidémiologie-Biostatistiques, EA MOS, EHESP, Rennes, France
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Aptel F, Lesoin A, Chiquet C, Aryal-Charles N, Noel C, Romanet JP. Long-Term Reproducibility of Diurnal Intraocular Pressure Patterns in Patients with Glaucoma. Ophthalmology 2014; 121:1998-2003. [DOI: 10.1016/j.ophtha.2014.04.039] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2013] [Revised: 12/31/2013] [Accepted: 04/21/2014] [Indexed: 10/25/2022] Open
|
43
|
May O, Merle N, Paule R, Noel C, Roumenina L, Fremeaux-Bacchi V, Frimat M. Analyse des propriétés de protection contre l’activation du complément et de l’expression d’un phénotype prothrombotique de l’endothélium glomérulaire rénal. Nephrol Ther 2014. [DOI: 10.1016/j.nephro.2014.07.330] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
44
|
Hennino M, Van Der Hauwaert C, Jomaa Z, Savary G, Buob D, Gnemmi V, Noel C, Cauffiez C, Glowacki F. Implication du microARN miR-21 dans la progression de la maladie de Berger. Nephrol Ther 2014. [DOI: 10.1016/j.nephro.2014.07.328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
45
|
Santanam L, Kashani R, Victoria J, Green O, Noel C, Wooten O, Michalski J, Mutic S, Gay H, Tanderup K. Feasibility of Online Adaptive Planning Using an Onboard Magnetic-Resonance Image Guided Radiation Therapy (MR-IGRT) System. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.525] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
46
|
Audinot JN, Hamdan A, Grysan P, Fleming Y, Noel C, Kosior F, Henrion G, Belmonte T. Combined SIMS and AFM study of complex structures of streamers on metallic multilayers. SURF INTERFACE ANAL 2014. [DOI: 10.1002/sia.5635] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- J.-N. Audinot
- SAM Department; Centre de Recherche Public Gabriel Lippmann; 41 rue du Brill 4422 Belvaux Luxembourg
| | - A. Hamdan
- Université de Lorraine, Institut Jean Lamour; UMR CNRS 7198, CS 50840 NANCY F-54011 France
| | - P. Grysan
- SAM Department; Centre de Recherche Public Gabriel Lippmann; 41 rue du Brill 4422 Belvaux Luxembourg
| | - Y. Fleming
- SAM Department; Centre de Recherche Public Gabriel Lippmann; 41 rue du Brill 4422 Belvaux Luxembourg
| | - C. Noel
- Université de Lorraine, Institut Jean Lamour; UMR CNRS 7198, CS 50840 NANCY F-54011 France
| | - F. Kosior
- Université de Lorraine, Institut Jean Lamour; UMR CNRS 7198, CS 50840 NANCY F-54011 France
| | - G. Henrion
- Université de Lorraine, Institut Jean Lamour; UMR CNRS 7198, CS 50840 NANCY F-54011 France
| | - T. Belmonte
- Université de Lorraine, Institut Jean Lamour; UMR CNRS 7198, CS 50840 NANCY F-54011 France
| |
Collapse
|
47
|
Abstract
BACKGROUND Bisphosphonates have been widely used for treatment of high bone resorption states. It lowers bone turnover by inhibiting osteoclasts bone resorption with various mechanisms of actions: inhibition of osteoclast formation and attachment to the bone surface, induction of metabolic injury, alteration of vesicle trafficking and induction of osteoclast apoptosis. Bone biopsies studies from patients under bisphosphonates have shown that some resorption parameters are decreased as expected but the number of osteoclasts seems not to be necessarily decreased. The description of osteoclasts morphology from patients treated with bisphosphonates has rarely been reported in the literature. CASE PRESENTATION We describe in this paper two patients treated with bisphosphonates from whom iliac crest bone biopsies have shown large, multinucleated and apoptotic osteoclasts that were not associated with bone resorption activities. The characteristics of these osteoclasts are described and the literature reviewed. CONCLUSION The appropriate recognition of these giant osteoclasts in bone tissues from patients treated with bisphosphonates is of primary importance for bone pathologists and should not be interpreted as signs of increased bone resorption as seen in hyperparathyroidism, bone cancer or Paget's disease of bone.
Collapse
Affiliation(s)
- Fabrice Mac-Way
- Laboratoire de Biologie Intégrative du Tissu Osseux, Inserm U1059, Université de Lyon, Saint-Etienne, France ; Division of Nephrology, CHU de Québec, L'Hôtel-Dieu de Québec Hospital and Research Center, Faculty of Medicine, Laval University, Quebec, Canada
| | - Andrea Trombetti
- Department of Internal Medicine, Centre Hospitalier Universitaire de Genève, Geneva University, Geneva, Switzerland
| | - Christian Noel
- Renal Division, CHU-Hôpital Calmette, Lille University, Lille, France
| | - Marie-Hélène Lafage-Proust
- Laboratoire de Biologie Intégrative du Tissu Osseux, Inserm U1059, Université de Lyon, Saint-Etienne, France
| |
Collapse
|
48
|
Feng Y, Kawrakow I, Olsen J, Parikh P, Noel C, Wooten H, Du D, Dempsey J, Mutic S, Hu Y. SU-E-J-142: Performance Study of Automatic Image-Segmentation Algorithms in Motion Tracking Via MR-IGRT. Med Phys 2014. [DOI: 10.1118/1.4888195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
49
|
Vantyghem MC, Quintin D, Caiazzo R, Leroy C, Raverdy V, Cassim F, Glowacki F, Hubert T, Gmyr V, Noel C, Kerr-Conte J, Pattou F. Improvement of electrophysiological neuropathy after islet transplantation for type 1 diabetes: a 5-year prospective study. Diabetes Care 2014; 37:e141-2. [PMID: 24855172 DOI: 10.2337/dc14-0320] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Affiliation(s)
- Marie-Christine Vantyghem
- INSERM, U859 Biotherapies for Diabetes, Lille, FranceEuropean Genomic Institute for Diabetes, Lille University, Lille, FranceDepartment of Endocrinology and Metabolism, Lille University Hospital, Lille, France
| | - Delphine Quintin
- Department of Endocrinology and Metabolism, Lille University Hospital, Lille, France
| | - Robert Caiazzo
- INSERM, U859 Biotherapies for Diabetes, Lille, FranceEuropean Genomic Institute for Diabetes, Lille University, Lille, FranceDepartment of Endocrine Surgery, Lille University Hospital, Lille, France
| | - Clara Leroy
- Department of Endocrinology and Metabolism, Lille University Hospital, Lille, France
| | - Violeta Raverdy
- INSERM, U859 Biotherapies for Diabetes, Lille, FranceEuropean Genomic Institute for Diabetes, Lille University, Lille, FranceDepartment of Endocrine Surgery, Lille University Hospital, Lille, France
| | - François Cassim
- Department of Clinical Neurophysiology, Lille University Hospital, Lille, France
| | - François Glowacki
- Department of Nephrology and Transplantation, Lille University Hospital, Lille, France
| | - Thomas Hubert
- INSERM, U859 Biotherapies for Diabetes, Lille, FranceEuropean Genomic Institute for Diabetes, Lille University, Lille, France
| | - Valery Gmyr
- INSERM, U859 Biotherapies for Diabetes, Lille, FranceEuropean Genomic Institute for Diabetes, Lille University, Lille, France
| | - Christian Noel
- Department of Nephrology and Transplantation, Lille University Hospital, Lille, France
| | - Julie Kerr-Conte
- INSERM, U859 Biotherapies for Diabetes, Lille, FranceEuropean Genomic Institute for Diabetes, Lille University, Lille, France
| | - François Pattou
- INSERM, U859 Biotherapies for Diabetes, Lille, FranceEuropean Genomic Institute for Diabetes, Lille University, Lille, FranceDepartment of Endocrine Surgery, Lille University Hospital, Lille, France
| |
Collapse
|
50
|
Pollet-Villard F, Chiquet C, Romanet JP, Noel C, Aptel F. Structure-Function Relationships With Spectral-Domain Optical Coherence Tomography Retinal Nerve Fiber Layer and Optic Nerve Head Measurements. ACTA ACUST UNITED AC 2014; 55:2953-62. [DOI: 10.1167/iovs.13-13482] [Citation(s) in RCA: 105] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Affiliation(s)
| | - Christophe Chiquet
- Department of Ophthalmology, University Hospital, CHU Grenoble, Grenoble, France 2INSERM U1042, Hypoxia and Physiopathology Laboratory, Joseph Fourier University, Grenoble, France
| | - Jean-Paul Romanet
- Department of Ophthalmology, University Hospital, CHU Grenoble, Grenoble, France
| | - Christian Noel
- Department of Ophthalmology, University Hospital, CHU Grenoble, Grenoble, France
| | - Florent Aptel
- Department of Ophthalmology, University Hospital, CHU Grenoble, Grenoble, France 2INSERM U1042, Hypoxia and Physiopathology Laboratory, Joseph Fourier University, Grenoble, France
| |
Collapse
|